Form 4: Chemed Corp Director McCarthy Acquires 277 Shares of Capital Stock
SEC Form 4 Filing
Director Eileen P. McCarthy reports the acquisition of 277 shares of Chemed Corp capital stock on May 19, 2025.
Summary
- Eileen P. McCarthy, a director of Chemed Corp, reported acquiring 277 shares of capital stock on May 19, 2025.
- The shares were acquired directly.
- Following the transaction, McCarthy beneficially owns 855 shares of Chemed Corp capital stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of a stock transaction by a company director. The purchase itself could be seen as mildly positive, indicating confidence, but the filing is simply a regulatory requirement.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/19/2025 | Date of transaction: Acquisition of 277 shares of capital stock. |
| 05/20/2025 | Signature date of the report. |
Keywords
CHEMED CORP, Director, Stock Acquisition, Beneficial Ownership, Capital Stock, Form 4, McCarthy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.